Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12613000904774
Ethics application status
Approved
Date submitted
8/08/2013
Date registered
13/08/2013
Date last updated
13/08/2013
Type of registration
Retrospectively registered
Titles & IDs
Public title
Comparative study between cabergoline and intravenous calcium in the prevention of ovarian hyper stimulation in women with polycystic ovarian disease undergoing Intracytoplasmic sperm injection (ICSI ).
Query!
Scientific title
Comparative study between cabergoline and intravenous calcium in the prevention of ovarian hyper stimulation in women with polycystic ovarian disease undergoing ICSI .
Query!
Secondary ID [1]
282992
0
ElKattan Protocol 100
Issuing authority ,Cairo University
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
subfertility
289817
0
Query!
ovarian hyperstimulation
289818
0
Query!
Poly cystic ovarian disease
289836
0
Query!
Condition category
Condition code
Reproductive Health and Childbirth
290170
290170
0
0
Query!
Fertility including in vitro fertilisation
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
0.5 mg oral Tablets cabergoline (Dostinex) daily for 8 days from the day of HCG injection. For once in the trial
To monitor the adherence to the medication we ask the patient for the drug tablet return.
Query!
Intervention code [1]
287707
0
Treatment: Drugs
Query!
Intervention code [2]
287714
0
Prevention
Query!
Comparator / control treatment
intravenous infusion of 10 % calcium gluconate 10 mL in 200 mL of physiologic saline on the day of ovum pickup.for once in the treatment cycle and each patient will undergo one treatment cycle during the trial.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
290199
0
The Occurrence of ovarian hyper stimulation which can be diagnosed clinically by patient symptoms accompanied by ultrasonography and laboratory investigation
Query!
Assessment method [1]
290199
0
Query!
Timepoint [1]
290199
0
10 months
Query!
Primary outcome [2]
290213
0
The severity of ovarian hyper stimulation which is detected by the need for ascitic drainage and the need for hospitalisation
Query!
Assessment method [2]
290213
0
Query!
Timepoint [2]
290213
0
10 months
Query!
Secondary outcome [1]
304089
0
chemical pregnancy rate :Positive (serum BHCG) 14 days following Embryo transfer
Query!
Assessment method [1]
304089
0
Query!
Timepoint [1]
304089
0
10 months
Query!
Secondary outcome [2]
304090
0
clinical pregnancy rate: positive pregnancy test and positive fetal heart beat by ultrasound after 6 weeks gestaional age
Query!
Assessment method [2]
304090
0
Query!
Timepoint [2]
304090
0
10 months
Query!
Secondary outcome [3]
304091
0
miscarriage rate: diagnosed by ultrasound /clinically
Query!
Assessment method [3]
304091
0
Query!
Timepoint [3]
304091
0
10 months
Query!
Secondary outcome [4]
304092
0
ectopic rate :diagnosed by ultrasound /clinically
Query!
Assessment method [4]
304092
0
Query!
Timepoint [4]
304092
0
10 months
Query!
Eligibility
Key inclusion criteria
-Subfertile women with polycystic ovarian disease
-serum FSH within normal limits( 1-12IU /l)
-at least 15 follicles or more ,more than 10 mm at the time of HCG administration
Query!
Minimum age
20
Years
Query!
Query!
Maximum age
40
Years
Query!
Query!
Sex
Females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
-patients need coasting for high risk of OHSS.
-patients need cycle cancellation.
-severe male infertility requiring testicular sperm extraction.
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Concealment is done by central randomisation by the computer .Entry of a woman’s initials, ID number, and date of birth on to a dedicated computer on the clinic, automatically generated the allocation group together with a study number, which was then recorded on the outcome sheet. These data could, if necessary, be verified against the computer randomisation at a later time.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3 / Phase 4
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
1/07/2013
Query!
Actual
15/07/2013
Query!
Date of last participant enrolment
Anticipated
30/04/2014
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
100
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
5284
0
Egypt
Query!
State/province [1]
5284
0
Cairo
Query!
Funding & Sponsors
Funding source category [1]
287761
0
Self funded/Unfunded
Query!
Name [1]
287761
0
Eman Elkattan
Query!
Address [1]
287761
0
Cairo University Teaching Hospital
1.Kasr AlAini street,Cairo Egypt
Postcode:11562
Query!
Country [1]
287761
0
Egypt
Query!
Primary sponsor type
Individual
Query!
Name
Eman Elkattan
Query!
Address
Cairo University Teaching Hospital
1.Kasr AlAini street,Cairo Egypt
Postcode:11562
Query!
Country
Egypt
Query!
Secondary sponsor category [1]
286487
0
None
Query!
Name [1]
286487
0
Query!
Address [1]
286487
0
Query!
Country [1]
286487
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
289707
0
Cairo University
Query!
Ethics committee address [1]
289707
0
1.Kasr AlAini street
Cairo,Egypt
Postcode:11562
Query!
Ethics committee country [1]
289707
0
Egypt
Query!
Date submitted for ethics approval [1]
289707
0
Query!
Approval date [1]
289707
0
Query!
Ethics approval number [1]
289707
0
Query!
Summary
Brief summary
we study novel approaches in the management of ovarian hyperstimulation in women suffering with Polycystic ovarian disease (PCO) and undergoing Intracytoplasmic sperm injection (ICSI).we compare the effect of intravenous calcium and oral cabergoline on the severity of ovarian hyperstimulation and outcome of ICSI as regard the pregnancy rate and miscarriage rate
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
42070
0
A/Prof Eman Elkattan
Query!
Address
42070
0
Cairo University
1.Kasr alAini street,Cairo,Egypt
Postcode:11562
Query!
Country
42070
0
Egypt
Query!
Phone
42070
0
+20 1222854159
Query!
Fax
42070
0
Query!
Email
42070
0
[email protected]
Query!
Contact person for public queries
Name
42071
0
A/Prof Eman Elkattan
Query!
Address
42071
0
Cairo University
1.Kasr alAini street,Cairo ,Egypt
Postcode:11562
Query!
Country
42071
0
Egypt
Query!
Phone
42071
0
+20 1222854159
Query!
Fax
42071
0
Query!
Email
42071
0
[email protected]
Query!
Contact person for scientific queries
Name
42072
0
A/Prof Eman Elkattan
Query!
Address
42072
0
Cairo University
1.Kasr alAini street,Cairo ,Egypt
Postcode:11562
Query!
Country
42072
0
Egypt
Query!
Phone
42072
0
+20 1222854159
Query!
Fax
42072
0
Query!
Email
42072
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF